<?xml version="1.0" encoding="UTF-8"?>
<p>A large United States electronic medical record dataset of the 2017–2018 influenza season was retrospectively evaluated to investigate the effectiveness of cell-based vaccines compared with egg-based vaccines for persons presenting to primary care practices.
 <sup>
  <xref rid="bibr41-2515135520908121" ref-type="bibr">41</xref>
 </sup> Patients who were 4 years of age to 65 years of age and older were enrolled from 1 August 2017, to 31 March 2018, and received quadrivalent influenza vaccines that were either cell-based (
 <italic>n</italic> = 92,192) or egg-based (
 <italic>n</italic> = 1,255,983). The overall estimate of RVE as defined by the prevention of ILIs was significantly higher for the cell-based quadrivalent inactivated influenza vaccine compared with the egg-based vaccine 36.2% (95% CI: 26.1, 44.9, 
 <italic>p</italic> &lt; 0.001).
 <sup>
  <xref rid="bibr41-2515135520908121" ref-type="bibr">41</xref>
 </sup>
</p>
